Jennison Associates’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,594
| Closed | -$6.06M | – | 615 |
|
|
2025
Q1 | $6.06M | Sell |
33,594
-269,927
| -89% | -$48.7M | ﹤0.01% | 404 |
|
|
2024
Q4 | $47.5M | Sell |
303,521
-106,536
| -26% | -$16.7M | 0.03% | 241 |
|
|
2024
Q3 | $74.6M | Sell |
410,057
-110,333
| -21% | -$20.1M | 0.05% | 163 |
|
|
2024
Q2 | $95.6M | Sell |
520,390
-150,345
| -22% | -$27.6M | 0.06% | 128 |
|
|
2024
Q1 | $119M | Sell |
670,735
-53,609
| -7% | -$9.54M | 0.08% | 103 |
|
|
2023
Q4 | $89.9M | Buy |
724,344
+383,495
| +113% | +$47.6M | 0.07% | 125 |
|
|
2023
Q3 | $39.5M | Buy |
340,849
+282,583
| +485% | +$32.8M | 0.03% | 208 |
|
|
2023
Q2 | $6.84M | Buy |
+58,266
| New | +$6.84M | 0.01% | 401 |
|
|
2022
Q2 | – | Sell |
-68,309
| Closed | -$4.55M | – | 662 |
|
|
2022
Q1 | $4.55M | Buy |
+68,309
| New | +$4.55M | ﹤0.01% | 461 |
|